ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Celltrion signs agreement for atherosclerosis drugs development
October 15, 2018Celltrion will have a preferential right to license-in the new drug candidates -
Novartis Enters into License Agreement with Galapagos, MorphoSys
July 24, 2018Novartis has entered into an exclusive license agreement with biotech companies Galapagos NV, Mechelen and MorphoSys regarding their compound MOR106. -
Prestige Biopharma and Alvogen Announce License and Supply Agreement to Commercialize Prestige´s Trastuzumab Biosimilar (Hervelous™) in Central and Eastern Europe
July 04, 2018Prestige BioPharma and Alvogen today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercialization of Prestige BioPharma´s Trastuzumab biosimilar (HD201; Hervelous™) in Central an -
Bristol-Myers Squibb enters into separate agreements with Biogen and Roche to License anti-eTau and
April 17, 2017Bristol-Myers Squibb Company (NYSE:BMY) announced that it has entered into two separate agreements to license BMS-986168 to Biogen and BMS-986089 to Roche. -
Ligand Expands Sermonix License to Oral Lasofoxifene
March 02, 2017Gains global development and commercialization rights -
Mayne Pharma Enters License/Supply Pact
March 01, 2017Mayne Pharma Inc. has entered into a long-term, exclusive license and supply agreement with Mithra Pharmaceuticals SA for Myring, an intravaginal hormonal contraceptive delivery device.
Pharma Sources Insight January 2025
